Spineology Receives $5MM Investment

Spineology received a US $5MM investment via convertible debenture from Hermed Capital, a private equity fund in Shanghai, China. Proceeds will fund commercialization, product development and clinical research.

Spineology received FDA 510(k) clearance for the Rampart One Anterior Lumbar Interbody Fusion system in 2Q17, and for Rampart Duo just...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us